Trial intelligence / Profile preview

HaRP: XR-NTX for Homeless Alcohol Dependence

NCT01932801Phase 2Completed

Sponsor
University of Washington
Start
Aug 2013
Primary completion
Oct 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of naltrexone in alcohol dependence, sponsored by University of Washington. Started Aug 2013; status: completed.

02

Drugs

naltrexone
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT01932801.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01932801.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call